Fig. 4
From: Efficacy of RCI001 as a therapeutic candidate of dry eye disease in a modified mixed dry eye model
Comparison of inflammatory cytokines in the corneoconjunctiva (CC) between the Neg, PBS, PDE, Lifitegrast, and RCI groups (a–g). Neg, naïve control; PBS, phosphate buffered saline; PDE, 1% prednisolone acetate; Lifite, 5% Lifitegrast; RCI, RCI001. Data are expressed as the mean ± standard error of the mean. *P < 0.05, one-way ANOVA with Tukey’s post hoc test, n = 9 per group.) RQ, relative quantification of mRNA expression